Skip to Main Content

INFORMATION FOR

    Pregnancy, Childbirth and the Puerperium | Women's Health, Phase Pilot

    Pharmacokinetics and Hepatic Safety of EGCG

    What is the purpose of this trial?

    A trial to assess the pharmacokinetics and hepatic safety of EGCG in women with and without uterine fibroids.

    • Trial with
      National Institutes of Health (NIH)
    • Ages
      18 years - 40 years
    • Gender
      Female only

    Contact Information

    For more information about this study, including how to volunteer, contact Michele Frank

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    • Last Updated
      03/18/2024
    • Study HIC
      #2000029129